HC Bokwang Industry: Q1 2026 Operating Loss Continues; Cash Plummet and Debt Rise
Consolidated Q1 2026 sales KRW 78.6B (vs. KRW 82.4B YoY), operating loss KRW 1.52B (vs. KRW 1.68B), net loss KRW 1.52B (vs. KRW 1.84B) - narrower loss
Separate operating loss KRW 1.52B, net loss KRW 1.52B
Cash and equivalents: plummeted from KRW 9.35B (end-2025) to KRW 61M (end-Q1 2026) due to dividend payment (KRW 1.82B), convertible bond redemption, etc.\- Borrowings: KRW 34.53B (end-2025: KRW 24.5B), debt ratio 89.7% (end-2025: 88.0%), net debt ratio 38.7% (end-2025: 16.4%)\- Issued 5th private convertible bond KRW 7B (conversion price KRW 2,945), early redemption of 4th CB KRW 18.9B
Year-end dividend: KRW 50 per share, total KRW 1.82B
Lawsuit from Kyungpook National University Hospital for KRW 200M pending